Quality of life and sexual function after TVT surgery versus Bulkamid injection for primary stress urinary incontinence: 1 year results from a randomized clinical trial
Autor: | Päivi Rahkola-Soisalo, Sari Tulokas, Anna-Maija Itkonen Freitas, Tomi S. Mikkola, Maarit Mentula |
---|---|
Přispěvatelé: | Department of Obstetrics and Gynecology, HUS Gynecology and Obstetrics, Clinicum, Doctoral Programme in Clinical Research, University of Helsinki |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
IMPACT Urology Urinary system Urinary Incontinence Stress 030232 urology & nephrology MULTICENTER Acrylic Resins Urinary incontinence FEMALE STRESS Polyacrylamide hydrogel Pelvic Organ Prolapse law.invention 03 medical and health sciences 0302 clinical medicine Quality of life Randomized controlled trial law 3123 Gynaecology and paediatrics Internal medicine Surveys and Questionnaires medicine Humans Clinical significance Suburethral Slings 030219 obstetrics & reproductive medicine Genitourinary system business.industry Obstetrics and Gynecology WOMEN Hydrogels 3126 Surgery anesthesiology intensive care radiology Distress Treatment Outcome SAFETY Quality of Life Original Article Female medicine.symptom Sexual function business Mesh sling Bulking Follow-Up Studies |
Zdroj: | International Urogynecology Journal |
ISSN: | 1433-3023 0937-3462 |
Popis: | Introduction and hypothesis To assess changes in quality of life (QoL) and sexual function outcomes at 1 year after tension-free vaginal tape (TVT) versus polyacrylamide hydrogel injection (PAHG). Methods In a randomized trial comparing TVT (n = 111) and PAHG (n = 113) treatments of stress urinary incontinence (SUI), we compared urinary incontinence and health-related QoL using the Urogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire, Short Form (IIQ-7), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) and RAND-36 Item Health Survey (RAND-36) at baseline and 1 year. Results UDI-6 and IIQ-7 showed improved incontinence-related QoL (p = 0.001) from baseline in both groups except for difficulty emptying the bladder and pain/discomfort. At 1 year, TVT patients experienced less urinary symptom-related distress compared to PAHG (p p p = 0.01 for PAHG) with higher scores for the physical section subscale (p p p p = 0.02) was detected for TVT, but not for PAHG. However, there was no difference between the groups (p = 0.78). Conclusions In primary SUI, TVT and PAHG treatments both improved QoL and sexual function at 1 year. However, incontinence and health-related QoL scores were better in the TVT group. More pain compared to the baseline was reported after TVT, although there was no difference between groups. Clinical significance needs to be evaluated in long-term follow-up. |
Databáze: | OpenAIRE |
Externí odkaz: |